SS-1 Novartis Initiatives Dear Doctor letter (Sept 2004) –Mailed to AMA list (Hem, Onc, Hem/Onc) –ADA list of oral surgeons –All urology offices purchasing.

Slides:



Advertisements
Similar presentations
High Resolution Italian studies Pamela Minicozzi Descriptive Studies and Health Planning Unit, Department of Preventive and Predictive Medicine, Fondazione.
Advertisements

BISPHOSPHONATE RELATED OSTEONECROSIS OF THE JAW (BRONJ)
Supplementary Figures. Data source: Canadian Cancer Statistics 2011.
Shafiepour,mohsen MD. Kerman university of medical sciences.
Smiling Stork Outreach Effort & Early Childhood Caries Prevention Workgroup.
The cost is $744 for the fall semester The cost for a spouse is $3110 * The cost for children is $1412 per child * The cost is billed to your bursar’s.
Hematology/Oncology Fellowship Kristie A. Blum, M.D. Gregory Otterson, M.D. The Ohio State University Department of Medicine, Division of Hematology &
22-s02 27-s02 25-s04 20-s03 20-s06,7 28-s01 20-s04 22-s01 27-s01 20-s05.
LEUKEMIA & LYMPHOMA SOCIETY TEAM IN TRAINING. THE LEUKEMIA & LYMPHOMA SOCIETY WORLDS LARGEST VOLUNTARY HEALTH ORGANIZATION DEDICATED TO FUNDING BLOOD.
Tuesday, June 23, Today’s discussion General cancer statistics Cancer in Canada PEI Statistics at a glance Impact.
Mary S. McCabe Survivorship Care Planning. National Directions Focus on recurrence Increasing expectations by patients and families Identification of.
CP-1 Osteonecrosis of the Jaw (ONJ) and Bisphosphonates Oncologic Drugs Advisory Committee March 4, 2005 Novartis Pharmaceuticals Oncologic Drugs Advisory.
© 2011 wheresjenny.com Types of Doctor-III. © 2011 wheresjenny.com Types of Doctor-III Plastic Surgeon: A plastic surgeon is the doctor who can literally.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 21 Antineoplastic Drugs.
Case for Support. Blood Cancers More than 1 million North Americans are fighting blood cancers, the third leading cause of cancer deaths. Early detection.
Delivering clinical research to make patients, and the NHS, better Lymphs & Haems Cancer Research Report Site Specific Group Meeting Weds 11 th March 2015.
The Role and Objectives of Patient Organizations Around the World A presentation by: Mark Krueger, MPH 27 March 2010.
Cancer Among Native Americans in Arizona and New Mexico Data Provided by Arizona Cancer Registry at the Arizona Department of Health Services and the New.
Second Annual Lymphoma Survivorship Conference. April 5, 2014.
Recurrence of Malignancy after Transplantation ANZDATA - Australian and New Zealand Dialysis and Transplant Registry NSW Cancer Council.
Postmarketing Safety Assessment of Osteonecrosis of the Jaw Pamidronate & Zoledronic Acid Division of Drug Risk Evaluation Office of Drug Safety FDA Carol.
Imran Ahmad, MD FACP. Consultant Medical Oncologist, KFSH &RC-Jeddah.
MEDICAL LABORATORY TECHNOLOGY What will I do? Perform tests on human blood, tissue and fluid Be a part of the health care team Help the doctor diagnose.
HEAD/NECK OF THE SKIN ANALYTIC vs. NON-ANALYTIC by YEAR N = 1800.
RCS 6080 Medical and Psychosocial Aspects of Rehabilitation Counseling Cancer.
Role of the Surgeon in Cancer Management A. Responsible for the initial diagnosis and management of solid tumors. B. Responsible for the Definitive Surgical.
Bisphosphonates effectively manage bone complications from cancer
Genetic Resources on the Web. Vast amounts of genetic information can be found on the Web. However, finding accurate and useful information can be tedious.
Cancer Over a hundred diseases are called cancer..
Core Benefit/Risk (CR)
The Genetic Component of a Common Disease The Paradigm of Cancer Genetics John Quillin, PhD, MPH, MS Virginia Commonwealth University Fall, 2005.
Cancer 101: A Cancer Education and Training Program for American Indians & Alaska Natives Cancer 101: A Cancer Education and Training Program for American.
INCLUDE THE NAME OF YOUR TYPE OF CANCER! MAKE SURE YOU INCLUDE SEVERAL APPROPRIATE PICTURES IN YOUR POWERPOINT! ONLY POINT FORM IS ALLOWED ON SLIDES (NO.
D-1 Bisphosphonate Bone Metastases Trials Proportion of Patients With Any SRE § (12, 010) Patients, % TreatmentN 3 mo6 mo9 mo12 mo Pamidronate Study 12.
The Cancer Awareness Program spans the continental US and reaches from Hawaii to Puerto Rico to Saipan. States with CAP States without CAP.
By: Kaylee Copas. What is cancer? Cancer is the uncontrolled growth of abnormal cells in the body. Cancerous cells are also called malignant cells.
Colorectal Cancer Update Patient Perspectives on Colorectal Cancer Section 6 Patient Grading of their Physicians, Patient Education Needs.
FRENCH high-resolution studies - Breast cancer: 1990, 1997, 2003, 2010 ? - Colorectal cancer: 1990, 1995, 2000, 2005, 2010 ? - Prostate cancer: 1995,
REGULATORY HISTORY of ZOMETA and AREDIA JAW OSTEONECROSIS (ONJ) Oncologic Drug Advisory Committee March 4, 2005 Nancy S. Scher, M.D.
CON - 1 Conclusions C David R. Parkinson Vice President, Global Head, Clinical Research and Development Novartis Pharmaceuticals Corporation.
Cancer: causes abnormal and uncontrolled cell growth to occur within body Because cancer cells continue to grow and divide, they are different from normal.
Liver cancer treatment India. Liver Cancer treatment The meaning of the liver cancer is the condition where abnormal cell division gives rise to the development.
Cancer Facts MS JYOTI SHAH CONSULTANT UROLOGICAL SURGEON SOURCE: CANCER RESEARCH UK.
Qualified Patient Criteria Combinations (Female and Male) Personal History of (any one of the below): Breast or Ovarian cancer (any age) Prostate or Pancreatic.
Within the Cancer Program in MUH doing the best research and providing the best care to our patients. This is the best cancer care hospital.cancer care.
The role of bisphosphonates in the treatment of bone metastases of genitourinary tumors Nuno Gil WHAT YOU HAVE TO KNOW XIV WORKSHOP ON ONCOLOGICAL UROLOGY.
Heath Reimbursement Account (HRA)
Overall Goal. Clinical Conversations: Nursing Care for Patients With Multiple Myeloma.
WHI Cancer Survivor Cohort (CSC)
Clinical staging of DrugRelated OsteoNecrosis of the Jaws: a new proposal Celentano A, Sadile G, Leuci S, Adamo D, Sammartino G, Mignogna MD, Ruoppo E.
Organization Name is participating in a pan-Canadian study to improve transitions in care Are you a cancer patient or survivor who completed treatment.
US Mortality, 2003 No. of deaths % of all deaths Rank Cause of Death
CANCER Carbon Co. Luzerne Schuylkill Pennsylvania TABLE 1. Distribution of Cancers by Type for Tamaqua Study Counties and Pennsylvania Based on
Your Symptoms Matter – Prostate Cancer
Slide set on: McCarthy PL, Owzar K, Hofmeister CC, et al
Figure 1. Overall survival of patients receiving alternative medicine (solid lines) vs conventional cancer treatment (dashed lines). Overall survival of.
Integrated Performance Report 26 October 2017
Bronx Community Health Dashboard: Other Cancers Last Updated: 01/09/2018 See last slide for more information about this project.
Ways your Oral Health Affects your Overall Health Oral Health.
Pennies For Patients E-Book
Incidence of nonskin cancers at five years
سرطان الثدي Breast Cancer
PLEASE INSERT YOUR LOGO HERE
Organization Name is participating in a pan-Canadian study to improve transitions in care Are you a cancer patient or survivor who completed treatment.
Common Cancers.
Standard 3.1 Patient Navigation Process
Social Media Day of Thanks
Living With & Beyond Cancer: SWAG Haematology SSG Update
PLEASE INSERT YOUR LOGO HERE
Louisiana Primary Care along Interstate Highways
Presentation transcript:

SS-1 Novartis Initiatives Dear Doctor letter (Sept 2004) –Mailed to AMA list (Hem, Onc, Hem/Onc) –ADA list of oral surgeons –All urology offices purchasing Zometa ® Rolled out patient brochure addressing oral health and ONJ Updated fair balance statement to include ONJ in all promotional materials Dear Doctor letter (Sept 2004) –Mailed to AMA list (Hem, Onc, Hem/Onc) –ADA list of oral surgeons –All urology offices purchasing Zometa ® Rolled out patient brochure addressing oral health and ONJ Updated fair balance statement to include ONJ in all promotional materials (NS22-11) Med Services ONJ.ppt slide 1

SS-2 Patient Outreach Regarding Osteonecrosis of the Jaw Patient advocacy group meetings (May 2004) –9 groups representing multiple tumor types (breast, myeloma, prostate, lung, and kidney, leukemia, lymphoma) –Additional follow-up to 14 advocacy groups (Dec 2004/early 2005) Planned activity: post ODAC briefing teleconference with patient advocacy groups Patient advocacy group meetings (May 2004) –9 groups representing multiple tumor types (breast, myeloma, prostate, lung, and kidney, leukemia, lymphoma) –Additional follow-up to 14 advocacy groups (Dec 2004/early 2005) Planned activity: post ODAC briefing teleconference with patient advocacy groups (NS22-18) Patient Advocacy ONJ.ppt slide 2

SS-3 Patient Brochure (NS21-1) “Taking Care of Yourself While Living With Cancer: Dental Health and Osteonecrosis of the Jaw” Novartis Patient Information Brochure

SS-4 Novartis Initiatives—Patient Education

SS-5 ONJ White Paper (NS21-1) “Taking Care of Yourself While Living With Cancer: Dental Health and Osteonecrosis of the Jaw” Novartis Patient Information Brochure